These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7269917)

  • 1. [Prevention of post-transfusion hepatitis. I. Evaluation of the effectiveness of donor selection by the test for HBsAg].
    Bondarenko MP; Stepanov GP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 May; (5):44-8. PubMed ID: 7269917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoradiometric analysis and the prevention of posttransfusion hepatitis B].
    Leĭbenzon AS; Malakhova TS; Anan'ev VA; Viazov SO; Shchegolev AS
    Vopr Virusol; 1988; 33(3):292-4. PubMed ID: 3176430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B virus markers among Ethiopian blood donors: is HBsAg screening necessary?
    Tsega E; Mengesha B; Nordenfelt E; Hansson BG; Lindberg J
    Trop Geogr Med; 1987 Oct; 39(4):336-40. PubMed ID: 3451408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of hepatitis B surface antigen by 2 different serological methods].
    Bilgehan H; Bilgiç A
    Mikrobiyol Bul; 1977 Jul; 11(3):365-70. PubMed ID: 927228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier.
    Larsen J; Hetland G; Skaug K
    Transfusion; 1990 Jun; 30(5):431-2. PubMed ID: 2360234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis B--significance for transfusion medicine].
    Jilg W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():20-6. PubMed ID: 8000250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-transfusion hepatitis. II. A sudden decrease in post-transfusion hepatitis associated with the elimination of donors with hyperbilirubinemia].
    Pintera J; Krácmar C; Pinterová A
    Cas Lek Cesk; 1985 Nov; 124(46):1423-7. PubMed ID: 4064089
    [No Abstract]   [Full Text] [Related]  

  • 8. Estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia.
    Mboi N; Olson JG; McGreevy PB; Tan R; Moeslichan S
    Int J Epidemiol; 1981 Dec; 10(4):367-72. PubMed ID: 7327835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus screening in contacts of blood donors with antibodies against core protein (anti-HBC), but without surface antigen (HBsAg).
    Fortes HM; Ribeiro LC; Perazolo GF; Souto FJ
    Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):195-9. PubMed ID: 16830712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study.
    Katchaki JN; Siem TH; Brouwer R; Brandt KH; van der Waart M
    J Virol Methods; 1980 Dec; 2(1-2):119-25. PubMed ID: 7228974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk of hepatitis infection of the recipients of blood from donors with HBs-antigenemia].
    Paktoris EA; Khukhlovich PA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):37-41. PubMed ID: 7102180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunoassay for hepatitis B surface antigen. An evaluation of commercial test kits.
    Nath N; Dodd RY; Fang CT
    Transfusion; 1983; 23(1):45-8. PubMed ID: 6829058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Williams e1 antigen in comparison with e2 antigen in hepatitis B antigen carriers and patients in hemodialysis unit.
    Ohori H; Yamada E; Tateda A; Ishida N
    J Med Virol; 1980; 6(1):61-74. PubMed ID: 6785391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemagglutinating test for HBsAg and antibodies in epidemiological practice].
    Orgel' MIa; Mel'nichenko TIu; Anan'ev VA; Goroshnikov SB; Matoshko GV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Dec; (12):65-8. PubMed ID: 3825358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our experience with the prevention of hepatitis B].
    Frolov AF; Orgel' MIa; Mel'nichenko TIu; Martsinkovskiĭ LT; Iakushev VG
    Gematol Transfuziol; 1987 Sep; 32(9):46-8. PubMed ID: 3692128
    [No Abstract]   [Full Text] [Related]  

  • 16. Ways of post-transfusion hepatitis prevention.
    Pintera J
    Czech Med; 1989; 12(3):149-57. PubMed ID: 2509173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection.
    Pintera J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of hepatitis B in the surgical clinic].
    Shalimov SA; Frolov AF; Radzikhovskiĭ AP; Orgel' MIa; Martsinkovskiĭ LT; Pokrasen NM; Shevchenko LF; Anan'ev VA; Tat'ianko NV
    Vestn Khir Im I I Grek; 1987 Jun; 138(6):133-6. PubMed ID: 3672774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies of the distribution of hepatitis B markers among blood donors and patients with post-transfusion hepatitis in the city of Sofia].
    Gubev E; Rashkov R; Dimitrova T; Sharankov N; Andonov A
    Vutr Boles; 1987; 26(3):38-43. PubMed ID: 3617705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of introducing a third-generation test for HBsAg in Danish blood donors.
    Wantzin P; Skovgaard L; Tygstrup N; Nielsen JO; Soerensen H; Dybkjaer E
    Liver; 1986 Jun; 6(3):173-7. PubMed ID: 3091978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.